NR4A2 and neoplasm: To confirm that antigen-mediated control of transgene expression was maintained in vivo, we adoptively transferred NR4A2/NGFR human CAR T cells into OVCAR-3 tumor bearing mice and observed tumor-site specific expression of NGFR (Supplementary Figs. 5D, E).